[go: up one dir, main page]

IL177406A0 - Piperazine urea derivatives for the treatment of endometriosis - Google Patents

Piperazine urea derivatives for the treatment of endometriosis

Info

Publication number
IL177406A0
IL177406A0 IL177406A IL17740606A IL177406A0 IL 177406 A0 IL177406 A0 IL 177406A0 IL 177406 A IL177406 A IL 177406A IL 17740606 A IL17740606 A IL 17740606A IL 177406 A0 IL177406 A0 IL 177406A0
Authority
IL
Israel
Prior art keywords
endometriosis
treatment
urea derivatives
piperazine urea
piperazine
Prior art date
Application number
IL177406A
Other languages
English (en)
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of IL177406A0 publication Critical patent/IL177406A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL177406A 2004-02-24 2006-08-10 Piperazine urea derivatives for the treatment of endometriosis IL177406A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04090065 2004-02-24
PCT/EP2005/002036 WO2005079769A2 (en) 2004-02-24 2005-02-23 Piperazine derivatives for the treatment of endometriosis

Publications (1)

Publication Number Publication Date
IL177406A0 true IL177406A0 (en) 2006-12-10

Family

ID=34878280

Family Applications (1)

Application Number Title Priority Date Filing Date
IL177406A IL177406A0 (en) 2004-02-24 2006-08-10 Piperazine urea derivatives for the treatment of endometriosis

Country Status (21)

Country Link
US (1) US20080119471A1 (es)
EP (1) EP1727526A2 (es)
JP (1) JP2007523126A (es)
KR (1) KR20070033961A (es)
CN (1) CN101090723A (es)
AR (1) AR048068A1 (es)
AU (1) AU2005215156A1 (es)
BR (1) BRPI0507985A (es)
CA (1) CA2556423A1 (es)
CR (1) CR8584A (es)
EA (1) EA200601514A1 (es)
EC (1) ECSP066836A (es)
GT (1) GT200500032A (es)
IL (1) IL177406A0 (es)
NO (1) NO20064298L (es)
PA (1) PA8624501A1 (es)
PE (1) PE20051129A1 (es)
SV (1) SV2006002017A (es)
TW (1) TW200539882A (es)
WO (1) WO2005079769A2 (es)
ZA (1) ZA200607970B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20080943A1 (es) * 2006-06-23 2008-09-27 Smithkline Beecham Corp Sal toluenosulfonato de 4-{[6-cloro-3-({[(2-cloro-3-fluorofenil)amino]carbonil}amino)-2-hidroxifenil]sulfonil}-1-piperazinacarboxilato de 1,1-dimetiletilo como antagonista del receptor de il-8
US8445674B2 (en) * 2009-10-21 2013-05-21 Hoffmann-La Roche Inc Heterocyclyl compounds
ES2703176T3 (es) 2010-03-11 2019-03-07 Univ New York Compuestos amido como moduladores de RORgammat y usos de los mismos
EA035256B1 (ru) 2013-07-18 2020-05-21 Новартис Аг Ингибиторы аутотаксинов, содержащие гетероарил-бензил-амидное ядро

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207665B1 (en) * 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
EP1534681A1 (en) * 2002-06-27 2005-06-01 Schering Aktiengesellschaft Substituted quinoline ccr5 receptor antagonists

Also Published As

Publication number Publication date
EA200601514A1 (ru) 2007-02-27
PA8624501A1 (es) 2006-07-03
US20080119471A1 (en) 2008-05-22
CA2556423A1 (en) 2005-09-01
KR20070033961A (ko) 2007-03-27
JP2007523126A (ja) 2007-08-16
GT200500032A (es) 2005-10-31
CN101090723A (zh) 2007-12-19
SV2006002017A (es) 2006-05-09
AU2005215156A1 (en) 2005-09-01
WO2005079769A2 (en) 2005-09-01
ZA200607970B (en) 2008-12-31
WO2005079769A3 (en) 2007-01-04
CR8584A (es) 2007-08-28
EP1727526A2 (en) 2006-12-06
NO20064298L (no) 2006-11-24
AR048068A1 (es) 2006-03-29
PE20051129A1 (es) 2006-02-16
ECSP066836A (es) 2006-11-24
TW200539882A (en) 2005-12-16
BRPI0507985A (pt) 2007-05-08

Similar Documents

Publication Publication Date Title
IL189659A0 (en) Ikk inhibitors for the treatment of endometriosis
PL1802579T3 (pl) Pochodne 3-aryloaminopirydynowe
EP1764360A4 (en) UREA DERIVATIVE
IL180680A0 (en) Piperazine derivatives useful for the treatment of gastrointestinal disorders
AP2007003980A0 (en) Dibenzylamine compounds and derivatives
IL180017A0 (en) Amino-5, 5-diphenylimidazolone derivatives for the inhibition of beta-secretase
IL180200A0 (en) 5-aza-7 deazapurine derivatives for treating flaviviridae
IL183216A0 (en) Nepetalactams and n-substituted derivatives thereof
IL180481A0 (en) Aryl-pyridine derivatives
IL174014A0 (en) Methods for the treatment of endometriosis
IL189048A (en) Uranium derivatives as 3-gsk inhibitors
IL177968A0 (en) Tetrahydropyridoindole derivatives
AP2007004157A0 (en) N- (N-sulfonylaminomethyl) cyclo-propanecarboxamide derivatives useful for the treatment of pain
IL179736A0 (en) Pyrrazolo-pyrimidine derivatives
IL182585A0 (en) Imidazo-benzodiazepine derivatives
IL183217A0 (en) Dihydronepetalactams and n-substituted derivatives thereof
IL177232A0 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
GB0414272D0 (en) OsK1 derivatives
GB0523609D0 (en) Piperazine derivatives
PL1763508T3 (pl) Sposób wytwarzania mocznika
ZA200607970B (en) Piperazine urea derivatives for the treatment of endometriosis
ZA200509590B (en) Nitrogen-containing heteroaryl derivatives for the treatment of HCV-infection
PL1959957T3 (pl) Pochodne pirymidyloaminobenzamidu do leczenia neurowłókniakowatości
EP1750698A4 (en) 5-ANILINO-4-HETEROARYLPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES
IL179670A0 (en) Heterocyclic compounds and processes for the preparation thereof